AFX — Carl Zeiss Meditec AG Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge CapFalling Star

Annual cashflow statement for Carl Zeiss Meditec AG, fiscal year end - September 30th, EUR millions except per share, conversion factor applied.

	R2020 September 30th	2021 September 30th	C2022 September 30th	2023 September 30th	2024 September 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	123	238	296	292	180
Depreciation
Non-Cash Items	58.7	110	52.3	98.4	27.1
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-64	-46.5	-230	-214	-92.7
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	179	363	188	251	247
Capital Expenditures	-45	-66.1	-82	-114	-152
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-26	-9.1	-10.9	2.88	-260
Acquisition of Business
Sale of Fixed Assets
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-70.9	-75.2	-92.9	-111	-412
Financing Cash Flow Items	-48.8	-224	8.21	-13.7	47.6
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-123	-286	-94.2	-135	176
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-16.4	1.24	0.29	2.87	9.68